Correlation Between CERo Therapeutics and LifeMD Preferred

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CERo Therapeutics and LifeMD Preferred at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CERo Therapeutics and LifeMD Preferred into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CERo Therapeutics Holdings and LifeMD Preferred Series, you can compare the effects of market volatilities on CERo Therapeutics and LifeMD Preferred and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CERo Therapeutics with a short position of LifeMD Preferred. Check out your portfolio center. Please also check ongoing floating volatility patterns of CERo Therapeutics and LifeMD Preferred.

Diversification Opportunities for CERo Therapeutics and LifeMD Preferred

-0.49
  Correlation Coefficient

Very good diversification

The 3 months correlation between CERo and LifeMD is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding CERo Therapeutics Holdings and LifeMD Preferred Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LifeMD Preferred Series and CERo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CERo Therapeutics Holdings are associated (or correlated) with LifeMD Preferred. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LifeMD Preferred Series has no effect on the direction of CERo Therapeutics i.e., CERo Therapeutics and LifeMD Preferred go up and down completely randomly.

Pair Corralation between CERo Therapeutics and LifeMD Preferred

Assuming the 90 days horizon CERo Therapeutics Holdings is expected to generate 24.67 times more return on investment than LifeMD Preferred. However, CERo Therapeutics is 24.67 times more volatile than LifeMD Preferred Series. It trades about 0.24 of its potential returns per unit of risk. LifeMD Preferred Series is currently generating about 0.07 per unit of risk. If you would invest  0.89  in CERo Therapeutics Holdings on September 1, 2024 and sell it today you would earn a total of  1.09  from holding CERo Therapeutics Holdings or generate 122.47% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy95.24%
ValuesDaily Returns

CERo Therapeutics Holdings  vs.  LifeMD Preferred Series

 Performance 
       Timeline  
CERo Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in CERo Therapeutics Holdings are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, CERo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
LifeMD Preferred Series 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in LifeMD Preferred Series are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable fundamental indicators, LifeMD Preferred is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

CERo Therapeutics and LifeMD Preferred Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CERo Therapeutics and LifeMD Preferred

The main advantage of trading using opposite CERo Therapeutics and LifeMD Preferred positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CERo Therapeutics position performs unexpectedly, LifeMD Preferred can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LifeMD Preferred will offset losses from the drop in LifeMD Preferred's long position.
The idea behind CERo Therapeutics Holdings and LifeMD Preferred Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Transaction History
View history of all your transactions and understand their impact on performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities